Anixa Biosciences, Inc. (FRA:CY71)

Anixa Biosciences Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Cash & Equivalents	1.24	1.27	0.92	12.36	29.13
Short-Term Investments	13.93	18.65	22.93	17.33	6.6
Cash & Short-Term Investments	15.17	19.92	23.84	29.69	35.73
Cash Growth	-23.84%	-16.44%	-19.68%	-16.91%	294.47%
Other Receivables	-	0.17	0.27	0.05	-
Receivables	-	0.17	0.27	0.05	-
Prepaid Expenses	0.71	1.27	1.24	0.47	0.28
Total Current Assets	15.89	21.36	25.36	30.2	36
Property, Plant & Equipment	0.19	0.23	0.17	0.21	0.25
Total Assets	16.08	21.59	25.52	30.41	36.26
Accounts Payable	0.17	0.53	0.21	0.27	0.14
Accrued Expenses	1.76	1.95	1.77	1.73	1.1
Current Portion of Leases	0.04	0.03	0.05	0.05	0.04
Total Current Liabilities	1.97	2.5	2.03	2.04	1.27
Long-Term Leases	0.16	0.2	0.12	0.18	0.22
Total Liabilities	2.13	2.7	2.15	2.21	1.49
Common Stock	0.33	0.32	0.31	0.31	0.3
Additional Paid-In Capital	266.51	260.43	252.22	247.12	239.93
Retained Earnings	-251.68	-240.75	-228.2	-218.39	-204.79
Treasury Stock	-	-0.01	-	-	-
Total Common Equity	15.16	20	24.34	29.05	35.44
Minority Interest	-1.21	-1.11	-0.97	-0.85	-0.67
Shareholders' Equity	13.95	18.89	23.37	28.2	34.77
Total Liabilities & Equity	16.08	21.59	25.52	30.41	36.26
Total Debt	0.2	0.23	0.18	0.22	0.26
Net Cash (Debt)	14.97	19.69	23.67	29.47	35.47
Net Cash Growth	-23.98%	-16.80%	-19.67%	-16.92%	294.01%
Net Cash Per Share	0.46	0.62	0.76	0.97	1.24
Filing Date Shares Outstanding	33.38	32.19	31.7	30.92	30.13
Total Common Shares Outstanding	33.01	32.19	31.15	30.91	30.05
Working Capital	13.92	18.86	23.33	28.16	34.73
Book Value Per Share	0.46	0.62	0.78	0.94	1.18
Tangible Book Value	15.16	20	24.34	29.05	35.44
Tangible Book Value Per Share	0.46	0.62	0.78	0.94	1.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.